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TNFa induces expression of the chemoattractant cytokine RANTES in
cultured mouse mesangial cells. We investigated the effect of several
immune-relevant cytokines on expression of the chemoattractant inter-
crine/chemokine RANTES in a mouse mesangial cell line (MMC). Fifty
ng/ml recombinant tumor necrosis factor alpha (TNFa) induced a
marked increase in RANTES transcripts after two hours. RANTES
mRNA remained elevated for 24 to 48 hours after stimulation, and could
be abolished by co-incubation with 30 g/ml of a neutralizing rabbit
anti-TNFa antibody. Protein expression of RANTES, as assessed by
indirect immunofluorescence and Western blotting, increased in MMCs
24 hours after TNFa stimulation. lnterleukin-1f3, tumor necrosis factor
beta (TNFI3), and lipopolysaccharide (LPS) also increased expression
of RANTES mRNA. In addition, RANTES mRNA expression was
stimulated in glomeruli harvested from rats following renal in vivo
perfusion with TNFa. Our results indicate that mesangial cells produce
the small cytokine RANTES. This factor, in concert with other
chemoattractants, may play a role in the glomerular recruitment of
inflammatory cells like macrophages/monocytes.
Bone marrow-derived macrophages/monocytes (M/M) play a
pivotol role in some types of glomerulonephritis [1, 2]. As
principal immune effector cells, M/M recruited to the glomeru-
tar tuft, generate and release factors that contribute to injury of
normal glomerular structures. Factors produced by activated
M/M include proteolytic enzymes such as collagenase and
elastase, interleukin I, thromboxane A2, leukotrienes, platelet
activating factor (PAF), and oxygen radicals [1—6]. This array of
released factors may in turn stimulate intrinsic glomerular cells
to proliferate, injure intact glomerular basement membrane and
disrupt the functional integrity of the filtration barrier resulting
in proteinuria, and a decreased glomerular filtration rate by
vasoconstriction 17, 8].
The mechanisms of M/M migration into the glomerulus are
not completely understood. Various factors have been sug-
gested to be chemoattractant for M/M including complement
components, platelet activating factor, and leukotrienes [1, 2,
8]. More recently, a novel class of proinflammatory cytokines
(Scy superfamily/intercrines/chemokines) with a molecular
Received for publication December 22, 1992
and in revised form May 5, 1993
Accepted for publication May 11, 1993
© 1993 by the International Society of Nephrology
weight of 8 to 10 kD has been characterized [9, 10]. Interleu-
kin-8 [11] and monocyte chemoattractant protein 1 (MCP 1; 12)
are probably the most thoroughly studied members of this
superfamily. Human RANTES was originally isolated from
human T cells [13]. We [14] and others [15] have recently cloned
the murine counterpart of RANTES. RANTES is a member of
the C-C-class of intercrines in which the conserved cysteine
residues are directly adjacent [9]. Recombinant RANTES has
been shown to exert chemoattractive abilities for M/M and T
cells of the memory subtype [16]. On the other hand, RANTES
expression is reduced in cultured T cells after cellular activation
with antigen [17]. Previous studies determined that murine
RANTES is also expressed in tubular epithelium, mesangial
cells, and whole kidney [14]. Since mesangial cells may play a
central role in the chemoattraction of effectors cells into the
glomerular tuft [1, 2], the present study was undertaken to
evaluate RANTES protein and mRNA expression in a murine
mesangial cell line by cytokines known to stimulate other
intercrines. Our studies demonstrate that TNFa induces
RANTES mRNA and protein in murine mesangial cells.
Methods
Cell culture
The present study was performed in a murine mesangial cell
line (MMC). These cells were originally harvested from naive
SJL/J (H-2°) mice and were subsequently transformed with a
non-capsid forming SV-40 virus [18]. MMCs were grown in
Dulbecco's Modified Eagle's Medium (DMEM, Gibco-BRL,
Eggenstein, Germany) containing 450 mg/dl glucose, 100 U/mI
of penicillin, 100 zg/ml of streptomycin, 5 mM glutamine, and
10% decomplemented fetal calf serum (Gibco-BRL). Cells were
grown at 37°C in 5% CO2 and passaged every 72 hours by
trypsination. We and others have extensively characterized the
properties of this cell line [18—20]. Various morphological and
functional criteria clearly demonstrate that MMCs represent
differentiated mesangial cells. They express receptors for an-
giotensin H and an Fc-receptor for immunoglobulins. MMCs
exhibit the typical spindle-like appearance and stain positive for
vimentin, desmin, collagens type I and IV but failed to bind
antibody recognizing the proximal tubular 3M-l antigen [18].
Recent studies addressing the effect of ambient glucose medium
concentrations on MMC proliferation showed no differences in
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growth characteristics between this cell line and primary mu-
rine mesangial cultures [19]. Furthermore, we have demon-
strated in pilot experiments that induction of RANTES by
cytokines is similar in MMCs and primary murine and rat
mesangial cell cultures.
Northern hybridizations
A total of i07 MMCs were made quiescent in DMEM without
serum for 24 hours, and were subsequently incubated for
different time periods with varies doses of the following medi-
ators: recombinant murine tumor necrosis factor alpha (TNFc;
Genzyme, Boston, Massachusetts; USA), recombinant human
tumor necrosis factor beta (TNF/3; Genzyme), recombinant
mouse interleukin-l beta (IL-l/3; Genzyme), mouse epidermal
growth factor (EGF; Genzyme), recombinant human platelet-
derived growth factor-AB (PDGF; Genzyme), and angiotensin
II (Ang II; Sigma, Deisenhofen, Germany). All mediators were
free of measurable endotoxin concentrations (endotoxin
<0.001 ng/rnl, endotoxin kit from Sigma). Rested MMCs were
also incubated with different concentrations of lipopolysaccha-
ride (LPS) from E. co/i, serotype 02:B6 (Sigma, endotoxin
> 10.000 U/mg LPS) for 24 hours. In order to test for the
specificity of the RANTES induction by TNFa, cells were
co-incubated with TNFs and 30 sg/ml of a neutralizing rabbit
anti mouse TNFa antiserum (Genzyme). Additional TNFa-
stimulated cells were treated with 30 sg/ml normal rabbit
serum. Some MMCs treated with 100 ng/ml LPS were also
co-incubated with 30 tg/m1 of the anti-mouse TNFa antiserum.
Cell layers were washed twice after incubation in RNAse-free
PBS (pH 7.2), and total RNA was isolated and extracted as
previously described [201. The quantity and purity of the
samples were assessed by measuring absorption at 260 and 280
nm. Total cellular RNA (20 jsg/lane) was denatured in forma-
mide-formaldehyde and electrophoresed through a 1.2% agar-
ose gel containing 2.2 M formaldehyde. The RNA was then
vacuum blotted onto a nylon membrane (Zetabind, Cuno,
Meriden, USA), and short-wave UV-crosslinked. Prehybridiza-
tion was performed overnight at 42°C in 5 x SSPE (20 x SSPE:
3.6 M sodium chloride, 0.2 M sodium phosphate, 20 ms EDTA;
pH 7.4); 5 x Denhardt's (100 >< Denhardt's: 2% Ficoll 400, 2%
polyvinylpyrrolidone, 2% bovine serum albumin; BSA), 150
p.gIml sonicated and denatured salmon sperm DNA, 0.1%
sodium dodecyl sulfate (SDS), and 50% formamide. An EcoR
I-Xho I insert from the murine RANTES clone pMuR3 [14], and
a Pst I fragment encoding the rat glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) [211 gene were radioactively labeled
using hexamer primers with S tCi [32P]deoxyadenosine 5'-
triphosphate (3000 Ci/mmol, New England Nuclear, Dreieich,
Germany). The labeled probes were separated from unicorpo-
rated nucleotides by Sephadex G-50 spin columns (Boehringer
Mannheim, Mannheim, Germany). Membranes were hybrid-
ized with 1 x 106 cpm/probe per ml hybridization buffer (5 x
SSPE, 2 x Denhart's, 150 sg/ml sonicated and denatured
salmon sperm DNA, 0.1% SDS, 5% dextran sulfate, and 50%
formaldehyde) for 24 hours at 42°C in a rotating drum. After
hybridization, membranes were washed twice in 2 X SSC, 0.5%
SDS for 30 minutes at 22°C, and subsequently in 0.4 )< SSC,
0.5% SDS at 65°C for 45 minutes. The membranes were then
autoradiographed with intensifying screens at —70°C for two to
four days. Blots were stripped for 60 minutes in 5 mM Tris-HCI
Fig. 1. Northern blot of 20 p.g total RNA isolated from MMCs stimu-
lated with different concentrations of recombinant murine TNFa (1 to
200 ag/mI). The blot was hybridized with a cDNA for murine RANTES.
Maximal induction of RANTES mRNA was seen with 50 ng/mI TNFa.
The blot was stripped and rehybridized with a probe for GAPDH. The
1300 bp GAPDH transcripts are shown underneath. Exposure time for
this blot was 24 hours.
(pH 8.0, 0.5% sodium pyrophosphate, 5 x Denhardt's, and 0.2
ifiM EDTA, pH 8.0) at 65°C, and subsequently rehybridized
with the probe encoding the housekeeping gene GAPDH to
account for small loading and transfer variations. Exposed films
were scanned with a laser densitometer (GS 300, Hoefer
Scientific Instruments, San Francisco, California, USA), and
the area under the curves were determined by Gaussian inte-
gration with the computer program GS 365W (Hoefer). Relative
changes in RNA were calculated after assigning hybridization in
control lanes a relative value of one [21, 221. Samples were
normalized for the signal intensity of the GAPDH hybridiza-
tions. All Northern blot experiments were repeated at least
twice.
In vivo studies
Male Wistar rats (SAVO-Ivanovas, Kissleg, Germany) with a
body weight of 200 g were anaesthetized by i.p. injection of
mactin (Byk Gulden, Konstanz, Germany), and placed on a
thermoregulated operating table to maintain body temperature
at 37°C. The left kidney was cannulated with a PE 40 polythyl-
ene catheter and was perfused for 30 minutes with TNF
redissolved in 0.9% NaCl with 1% BSA (1 g TNFa/hr/kg body
wt). The kidneys of control animals were perfused only with
l
l
i
Controls
llOObp —Ø"
GAPDH —4.
p
0.5 hr
2 hr
6 hr
24 hr
48 hr
Controls
TNFa
Controls + anti-TNFa ab
TNFa + anti-TNFa ab
Controls + normal serum
TNFct + normal serum
llOObp —•—ø S
GAPDH—* $ s
H
Wolfe! a!: RANTES and mesangial cells 797
Fig. 2. Treatment of quiescent cells with a single
dose of 50 nglml TNFa for various time periods.
Stimulation with TNFa for two hours increased
RANTES expression which was maximally induced
after 24 hours of stimulation. Exposure to film was
72 hours for RANTES and two hours for GAPDH in
this experiment.
Fig. 3. MMCs were treated with 50 ng/ml
TNFa in the presence or absence of 30 g/ml
neutralizing rabbit anti-TNFa antiserum for
24 hours. Additional cells were incubated with
the same concentration of normal rabbit
serum. The anti-TNFa antibody partly
abolished the TNFa-mediated increase in
RANTES transcripts. Normal rabbit serum
had no effect. The blots were exposed to film
for 24 hours and two hours for RANTES and
GAPDH, respectively.
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0.9% NaCI and 1% BSA. Blood pressure was measured by a PE
50 polyethylene catheter which was inserted into the right
carotic artery and connected to a pressure transducer. Kidneys
from four to five rats were pooled on ice and the cortices were
separated from the medulla and sliced into small pieces. Gb-
meruli were isolated by differential sieving technique in ice-cold
RNAse-free PBS according to methodology established for this
laboratory [23]. The purity of the samples was controlled by
light microscopy. For the preparations of single cell suspen-
sions, glomeruli were incubated in PBS containing 1 mg/mi
Trypsin (Sigma), 1 mg!ml Collagenase Wuthington (Seromed,
Berlin, Germany), and 0.05 mg/mI DNAse type IV (Sigma) for
30 minutes at 37°C in a shaking water bath. After this incuba-
tion, cells were spun down, washed five times in ice-cold PBS,
and lysed in 10 ml of 25 m sodium citrate (pH 7.0), 0.5%
sarcosyl, and 0.1 M 2-mercaptoethanol. RNA was extracted as
previously described and 20 ig total RNA was loaded per lane.
Signals were quantitated by laser densitometry and normalized
for GAPDH hybridizations.
Immunofluorescence
MMCs were grown in glass slide chambers, incubated for 24
hours with serum-free DMEM medium, and were subsequently
stimulated for another 24 hours with 100 ng/ml TNFa. The cells
were fixed at —20°C in acetone for 10 minutes before their
staining. Slides were incubated with a 1:60 dilution of a poly-
clonal rabbit antibody generated against a human RANTES
fusion protein expressed in the 590 vector (prepared by Drs.
Peter Nelson and Alan Krensky). Previous studies using solid- Fig. 5. Stimulation of IVIMCs for 24 hours with recombinant mouseJL-J/3 also leads to an induction of RANTES transcripts which were,
phase radjoimmunoassay using recombinant intercrines however, somewhat smaller than the TNFa-mediated induction.
RANTES, MIP-la, MIP-l/3, and IL-8 demonstrated the speci-
ficity of this antiserum for RANTES 1141. We have also PBS, the stain was developed with 1:80 diluted affinity-purified,
previously demonstrated that preimmune serum did not stain FITC-labeled goat anti-rabbit IgG (Miles Scientific, Munich,
MMCs or a proximal tubular cell line [14j. After washing in Germany). For quantification of immunofluorescence staining,
Fig. 4. Recombinant human TNT-/i induced a
2.13-fold increase in RANTES mRNA only at
higher concentrations (100 ng/mI for 24 In-).
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Fig. 6. Northern blot of total RNA harvested from MMCs treated for 24 hours with different concentrations of LPS from E. coli. LPS induced
a strong increase in RANTES mRNA in a dose-dependent manner.
a total of 50 cells in each group was evaluated for positive
staining by a blinded investigator.
Western blotting
A total of 108 quiescent MMCs were stimulated for 24 hours
with 100 nglml TNFa, washed in ice-cold PBS, and scraped off
the culture flask in 150 l of disruption buffer (60 mrs's Tris-HCI,
pH 6.8, 2% SDS, and 100 mrs's dithiothreitol). In addition, cell
culture supernatants from control cells and cells treated with
TNFa were precipitated by adding absolute ethanol (final
concentration 33%, vol/vol) at 4°C overnight [18]. The samples
were centrifuged at 4°C and the pellets were resuspended in 100
itl disruption buffer. As a positive control, 5 g of commercially
available recombinant human RANTES (Genzyme) were also
resuspended in disruption buffer. All samples were boiled for 10
minutes, centrifuged and the protein concentrations measured
in the supernatants by a modification of the Lowry method
which is insensitive to the concentrations of SDS and dithio-
threitol used [24]. Equal amounts of protein (5 jg/1ane) were
loaded onto a denaturing 20% SDS-polyacrylamide gel. Low
molecular weight Rainbow° markers (Amersham, Braunsch-
weig, Germany) which comprise 2,350 to 46,000 kD were used
as standards. Proteins were electroblotted to nitrocellulose
(Hybond-N, Amersham) in 25 mrs's Tris-HCI, 190 mrs glycine,
and 20% methanol. Membranes were then stained for 10 min-
utes in a 0.2% Ponceau S (Sigma) solution to test for complete
protein transfer. The blots were blocked in 8% non-fat dry milk
in 20 mrs's Tris-HCI (pH 7.2), 137 mivi NaCI, and 0.1% Tween 20. Fig. 7. Co-incubation of MMCs with 100 ng/mILPS and 30 gImlof aThe membranes were incubated for one hour with a 1:600 neutralizing anti-mouse TNFci antibody for 24 hours did not abolish the
dilution of the polyclonal rabbit anti-human RANTES fusion LPS-mediated induction of RANTES transcripts.
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Fig. 8. Indirect immunofluorescence staining
of MMCs grown in glass chambers with a
polyclonal antibody generated against a
human RANTES fusion protein. Cells grown
in control medium (A) showed only little
RANTES protein expression, whereas MMCs
incubated for 24 hours in the presence of 100
ng/ml TNFa revealed a marked increase in
cytoplasmatic staining for RANTES protein(B). The exposure time for (A) was three
times as long as for picture (B), Preimmune
serum demonstrated no visible staining of
cells (data riot shown). 400 x original
magnification.
protein antibody [14]. The secondary antibody was a donkey
peroxidase-labeled anti-rabbit IgG. Peroxidase labeling was
developed with luminiscence immunodetection (ECL Western
Blotting System, Amersham) according to the manufacture's
recommendations. Blots were exposed in a darkroom for 10
seconds to film (Hyperfilm-ECL, Amersham). Western blot
experiments with separate stimulation of cells and electro-
phoresis of proteins were repeated twice.
Results
RANTES mRNA expression in MMCs
The present study was performed to test the effects of varies
cytokines and growth factors on the expression of the chemoat-
tractant RANTES in a mouse mesangial cell line. Dose-re-
sponse curves revealed that incubation of cells with 50 nglml
recombinant murine TNFa induced the highest expression of
RANTES mRNA (Controls 1.00; 1 ng/ml 1.03; 5 ng!ml 2.51; 10
ng/ml 1.81; 50 ng/ml 3.85; 100 ng/ml 3.71; 200 nglml 1.83-fold
increases in relative mRNA levels; Fig. 1). As shown in Figure
2, a single dose of 50 ng/ml TNFa induced RANTES expression
after two hours of stimulation in quiescent murine mesangial
cells. The maximal expression was detectable after 24 hours
(Controls 1.0; 0.5 hr 1.33; 2 hr 2.60; 6 hr 5.58; 24 hr 6.33; 48 hr
5.83-fold increases in relative mRNA levels). To test for the
specificity of TNFa-induced RANTES expression, cells were
co-incubated with 30 Wml of a neutralizing polyclonal anti-
murine TNFa antibody and 50 ng/ml TNFn for 24 hours. Figure
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Fig. 9. Western blot of 5 g protein obtained from lysates (lys) of MMCs grown for 24 hours in control medium or medium supplemented with
100 ng/ml TNFa. No apparent RANTES expression in quiescent control cells is visible. TNFa, however, induced a protein band migrating at 8
to 10 kD under denaturing conditions in a 20% SDS-polyacrylamide gel. In addition, an increase of RANTES protein is also seen in
ethanol-precipitated cell culture supernatants (sup) from MMCs exposed to 100 ng/ml TNFa for 24 hours as compared to control supernatants.
Recombinant human RANTES (5 g) was also electrophoresed under denaturing conditions and Western blotted to serve as a positive control.
The relative positions of molecular weight markers are shown on the left side.
3 revealed that the anti-TNFa antibody abolished the TNFa-
mediated increase in RANTES mRNA by more than 75%.
Normal rat serum (30 g/m1) had no significant effect on
TNFa-stimulated RANTES mRNA expression (Controls 1.0;
50 ng/ml TNFa 8.66; Controls + anti-TNFa antibody 0.98; 50
ng/ml TNFa + anti-TNFa antibody 3.44; Controls + normal
serum 1.0; 50 ng/ml TNFa + normal serum 7.20-fold increases
in relative mRNA levels). In contrast to TNFa, recombinant
human TNF/3 induced a more modest increase in RANTES
expression at relatively high levels (100 ng/ml) (Fig. 4; Controls
1.0; 25 nglml 1.58; 100 nglml 2.13-fold increases in relative RNA
levels). Recombinant mouse IL-1f3 also lead to an induction of
RANTES mRNA in MMCs (Fig. 5; controls 1.00; 5 ng/ml 5.31;
50 ng/ml 2.71-fold increases in relative RNA levels). We next
wished to determine whether LPS was capable to induce
RANTES mRNA accumulation. Therefore, MMCs were incu-
bated for 24 hours with different concentrations of LPS. LPS in
the concentration range of 10 to 2000 ng/ml stimulated
RANTES expression (controls 1.00; 1 ng/ml 1.22; 10 ng/ml 1.60;
50 nglml 2.32; 100 ng/ml 3.07; 500 nglml 3.50; 1000 nglml 3.40;
2000 nglml 2.57-fold increases in relative mRNA levels; Fig. 6).
However, as shown in Figure 7, 30 jig/mI neutralizing anti-
TNFa antibody did not abolish the induction of RANTES
mRNA by 100 ng/ml LPS (Controls 1.00; 100 nglml LPS 9.70;
100 ng/ml LPS + 30 jig/mI anti-TNFa antibody 9.10-fold
increases in relative mRNA levels). Various concentrations of
PDGF, EGF, or Ang II over several incubation periods (up to
72 hr) did not significantly change steady-state mRNA levels for
RANTES in MMCs (data not shown).
immunofluorescence
To test whether the TNFa-stimulated increases in RANTES
mRNA levels are associated with changes in protein expres-
sion, MMCs were grown in glass chamber slides in the presence
of 50 nglml TNFa or control medium. Acetone fixed cells were
subsequently stained with a polyclonal antibody generated
against a human RANTES fusion product. Indirect immunoflu-
orescence staining was documented by photography. Figure 8A
shows MMCs incubated in control medium for 24 hours. Only
very weak intracellular staining for RANTES is present (the
microscopic picture was taken with an exposure time of 15
seconds). One hundred ng/ml TNFa for 24 hours increased
immunostaining for RANTES significantly (Fig. 8B, photo-
graph with an exposure time of only 5 see). MMCs exposed to
TNFcr showed marked contraction as previously shown [251.
We tried to quantitate immunofluorescence by counting posi-
tive stained cells. Only 2.5 of a total of 50 cells grown in control
medium stained positive with the anti-RANTES antibody,
whereas 43 of 50 MMCs grown in 100 ng/ml TNFa revealed
immunofluorescence staining (mean values from 2 independent
experiments).
Western blotting
A total of 5 jig protein from lysed MMCs treated with 100
ng/ml TNFa or control medium for 24 hours was separated
under denaturing conditions on a 20% SDS-polyacrylamide and
blotted to nitrocellulose. Detection with anti-human RANTES
serum revealed a distinct band of approximately 8 to 10 kD in
lysates from cells treated with TNFa, whereas no band was
readily visible in MMC lysates prepared from control cells (Fig.
9). In addition, an increase in staining for RANTES was
detected in Western blots of ethanol-precipitated proteins from
cell culture supernatants harvested from cells treated with
TNFa compared to control supernatants. Staining of the mem-
brane with Ponceau S revealed that this difference was not due
to uneven loading of the gel (data not shown). We also used 5 jig
of recombinant human RANTES as a positive control in the
Western blot experiments (Fig. 9).
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In vivo perfusions of kidneys with TNFa
We finally tested whether the TNFa-stimulated expression of
mRNA for RANTES is confined to the cell culture situation or
is also operative in vivo. Kidneys of anesthetized rats were
perfused with 1 gIhr/kg body weight TNFa for 30 minutes.
This dose was derived from studies performed by Bertani and
colleagues [261 in rabbits where renal perfusion with 0.8 g/
hr/kg body weight TNFa for five hours exhibited glomerular
endothelial cell changes and polymorphonuclear cell accumu-
lation was observed, but not with lower TNFa concentrations.
Mean arterial blood pressure remained stable in our experi-
ments during perfusion for 30 minutes with the TNFc dose
used. In initial pilot experiments, we evaluated higher concen-
trations of TNFa which, however, induced systemic hypoten-
sion. Only very few RANTES transcripts could be detected in
20 tg total RNA isolated from glomerular single cell suspen-
sions harvested from kidneys which were perfused with control
solution (Fig. 10). In contrast, renal perfusion with TNFs
induced RANTES mRNA expression (Controls 1.0; TNFs
1.8-fold increase in relative mRNA levels).
Discussion
The destruction of glomerular integrity and loss of glomerular
function is closely associated with the appearance of an inflam-
matory cell infiltrate in many types of glomerulonephritis [1, 2].
The mechanisms leading to the glomerular recruitment of these
cells are, however, not completely understood. Several studies
have demonstrated that such diverse factors as leukotrienes,
C5a, interleukin-8, and MCP-1 may play a role in chemoattrac-
tion of M/M into the glomerular tuft [1, 2, 27—29]. It seems
reasonable that intrinsic glomerular cells may play a pivotal part
in producing and releasing such factors.
The present study is the first to address the effects of different
mediators on expression of the chemoattractive cytokine
RANTES in cultured mesangial cells. It has been demonstrated
that recombinant RANTES is chemoattractive for M/M [16]. In
addition, this intercrine also exhibits chemoattraction for T
cells, eosinophil and neutrophil leukocytes [16, 30]. TNFa was
identified in the present study as a strong mediator of the
induction of RANTES mRNA and protein expression in cul-
tured mesangial cells. IL-l/3 and TNF were somewhat less
potent in stimulation of RANTES expression. LPS over a wide
range of concentrations also induced RANTES mRNA in
MMCs. Baud and co-workers provided convincing evidence
that LPS induced the release of TNFa from mesangial cells
[3l}. Glomeruli have been identified as the main source of
TNFa production when systemic endotoxin is administered to
transgenic animals bearing a chimeric gene construct in which
the TNFa coding sequence is replaced by a reporter gene 132].
However, treatment of MMCs with LPS in the presence of
neutralizing anti-TNFa antibody in a concentration which abol-
ished TNFa effects, failed to block induction of RANTES
mRNA, suggesting that LPS-induction of RANTES is probably
not mediated by endogenous TNFa. Thus, we hypothesize that
mesangial induction of RANTES during systemic endotoxemia
by LPS and/or TNFa may explain why inflammatory cells
infiltrate the glomerulus in sepsis [33].
An increase in steady-state mRNA levels for RANTES can
be due to transcriptional activation and/or stabilization of
Fig. 10. Northern blot of 20 g total RNA prepared from glomerular
single cell suspensions harvested from kidneys after in vivo perfusion
with control buffer (controls) or TNFa (1 .tg/hr body wt for 30 mm).
Kidneys from four to five rats were pooled for this blot. No RANTES
transcripts are detectable in control glomeruli. In vivo perfusion with
TNFa for 30 minutes induced some transcripts (quantification by laser
densitometry revealed an 80% increase in RANTES expression).
transcripts. Using nuclear run-off experiments we have prelim-
inary evidence that the increase is, at least to some extent, due
to a stimulation of gene transcription by TNFa (unpublished
observations). TNFa increases phospholipase A2 activity and
induces the release of arachidonic acid as well as the accumu-
lation of intracellular cAMP [34, 35]. Current studies in our
laboratory focus on signal transduction pathways possibly
involved in TNFa-stirnulated RANTES expression.
Induction of RANTES by TNFa is not limited to the cell
culture. Perfusion of kidneys with TNFa caused induction of
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RANTES mRNA expression in isolated glomeruli. The cellular
source of this stimulated production in the glomerulus remains
to be established. Although the accumulation of RANTES
mRNA in whole glomeruli after TNFa perfusion is much
weaker than that seen in cell culture, the kidneys were only
perfused for 30 minutes. Furthermore, a dose of TNFa was
selected which did not induce systemic hypotension in order to
evaluate RANTES expression without altering hemodynamic
factors. Interestingly, infusion of TNFa into rabbits causes
endothelial cell swelling and polymorphonuclear leukocyte ac-
cumulation [261. Whether this leukocyte attraction into the
glomerulus is caused by an increase in local glomerular
RANTES production is an attractive, although unproven hy-
pothesis.
RANTES is not the only proinflammatory cytokine produced
by mesangial cells after TNFa stimulation. Previous studies
have identified induction of interleukin-8 [271 and MCP-l
mRNAs and proteins [27, 361 following TNFa treatment of
cultured human mesangial cells. Thus, it appears likely that
different chemoattractant cytokines are produced by mesangial
cells which may orchestrate in a complex network the recruit-
ment of proinflammatory cells into the glomerulus.
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